Hepatitis B virus X protein (HBx) of the hepatitis B virus (HBV) was strongly implicated in angiogenesis and metastasis during hepatocarcinogenesis. Here, we explored the possibility of cross-talk between HBx and hypoxia inducible factor-1α (HIF-1α), a potent transcriptional inducer of angiogenic factors. First, we showed that stability of HIF-1α protein was increased by HBx in HBx-inducible Chang liver cells as well as in transient HBx expression system of non-hepatic cells. Immunofluorescence studies revealed that the HBx-induced HIF-1α was partially translocated into nucleus in majority of cells, while additional CoCl 2 -induced hypoxic condition caused complete nuclear translocation. Second, HBx induced both phosphorylation of HIF-1α and activation of p42/p44 mitogen-activated protein kinases (MAPKs), which were synergistically enhanced in the presence of CoCl 2 . Further, HBx enhanced transcriptional activity of HIF-1α in the reporter genes encoding hypoxia response element or VEGF promoter. Either treatment of MEK inhibitor, PD98059, or coexpression of dominant-negative MAPK mutants abolished the HBx-induced transcriptional activity, protein stability, as well as nuclear translocation of HIF-1α, suggesting that HBx activates HIF-1α through MAPK pathway. Third, the association of HIF-1α with VHL was decreased but that with CBP was enhanced in the presence of HBx, suggesting the molecular mechanism by which HBx enhances the protein stability and transactivation function of HIF-1α. Finally, we demonstrated that expression of HIF-1α and VEGF was increased in the liver of HBx-transgenic mice, suggesting that the crosstalk between HIF-1 α and HBx may lead transcriptional activation of HIF-1α target genes, which play a critical role in hepatocarcinogenesis.
INTRODUCTION

Hepatitis B virus (HBV)
1 is strongly associated with the development of hepatocellular carcinoma (HCC) , and yet, the mechanism by which HBV induces events leading to HCC is not clearly elucidated.
One of the open reading frames encoded by the HBV genome is a regulatory X protein (HBx), which is a multifunctional transactivator of 16.5 kDa that is required for the transcription of the viral genome (reviewed in 1). HBx activates signal transduction cascades, including the Ras/Raf/mitogen activated protein kinase (MAPK), c-Jun N-terminal kinase, Src-dependent pathways and Jak1 tyrosine kinase, thereby results in the activation of AP-1, NF-κB, and signal transducers and activators of transcriptions (STATs), the major transcriptional factors associated with the proliferation and differentiation signals of liver cells (reviewed in 2). HBx protein also interacts with the tumor suppressor p53, resulting in loss of the protein function (3) (4) (5) .
Such pleiotropic effects of HBx may contribute to HBx-induced hepatocarcinogenesis.
Hypoxic stress in solid tumors is known to be a strong stimulus for new blood vessel formation which is termed angiogenesis (reviewed in 6, 7). One of the most angiogenic growth factors in tumors could be vascular endothelial growth factor (VEGF) that induces endothelial cell proliferation (8) . The expression of VEGF is increased during exposure to hypoxia, and the hypoxia-mediated response depends on hypoxia regulated element (HRE) sequences in the 5' and 3' regions of the VEGF gene that specifically bind to and transcriptinally activated by the hypoxia inducible factor-1 (HIF-1) (9, 10). HIF-1 comprises α and β dimerization with HIF-1β, DNA binding, and recruitment of transcriptional co-activators such as CREB binding protein (CBP)/p300 (16) . These processes are regulated by post-translational modifications in that phosphorylation of HIF-1α via the Ras/Raf/-MEK-p42/p44 signaling pathway leads to enhanced transactivation function of HIF-1α (17) (18) (19) . Eventually, HIF-1 activates the transcription of diverse genes encoding proteins that function to increase oxygen delivery, such as erythropoietin, to allow metabolic adaptation such as glucose transporters and glycolytic enzymes and to promote cell survival such as insulinlike growth factor II (IGF-II) in response to hypoxia (reviewed in 20). Upregulation of HIF-1α was observed in a broad range of cancers including breast and prostate cancer, which was correlated well with increased vascularity and metastatic potential, indicating that the expression of HIF-1α is associated with tumor progression (21, 22) .
HBx has been strongly implicated in angiogenesis and metastasis during hepatocarcinogenesis.
The expression of IGF-II, which has a potential angiogenic activity, was enhanced in the HBx-stable transfectants (23, 24) . HBx bearing cells showed decreased adhesion to fibronectin and induced a migratory phenotype in a CD44-dependent manner, indicating a role of HBx in invasion and metastasis (25, 26) .
Importantly, the expression of VEGF and new blood vessel formation were increased in the hepatocytes that stably express HBx (27) . Although HIF-1 is a major transcription factor known to regulate angiogenic factors such as VEGF and IGF-II, the role of HBx in transcriptional function of HIF-1 has not been investigated. In the present investigation, therefore, we explored the possibility of cross-talk between HBx and HIF-1α and showed for the first time that the HBx enhances transcriptional activity of HIF-1α probably through activation of MAPK pathway. Our results support the important role of HBx in angiogenesis and tumor progression in the HBV-associated hepatocarcinogenesis.
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Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)--Total RNA was prepared using
RNeasy kit (Qiagen Inc.). PCR reaction was performed as described previously with specific primers for HIF-1α ( forward: 5'-CAAGTGCATCATTAAGACTG-3', reverse: 5'-GGCTGCTCCAGGTCCTGGCG-3'), VEGF (forward: 5'-TGGAGTTTGCTAAACGTCTG-3', reverse: 5'-GTAGCTTATCTACTTTTGTC-3'), HBx (forward: 5'-GCTCTAGAATGGCTGCTAGGCT-3', reverse: 5'-CCCAAGCTTTTAGGCAGAGGTG-3') and β-actin (5'-CGTGGGCCGCCCTAGGCACCA-3', reverse: 5'-TTGGCTTAGGGTTCAGGGGGG-3') (28) . Genes were analyzed under the same conditions used to exponentially amplify the PCR products. Immunocytochemistry-Chang and Chang X-34 cells (7.5 x 10 4 cells/chamber) that had been plated the previous day on 4-chamber slide glass were treated with 100 µM CoCl 2 or vehicle in the presence or absence of 2 µg/ml doxycycline for 24 h. The cells were fixed with 50% Aceton/50% Methanol for 5 min and then permeabilized with 0.1% Triton X-100 in PBS for 10 min at RT. The cells were incubated in blocking solution of 3% FBS in PBS for 1 h and then stained with anti-HIF-1α antibody diluted into 1:100 in PBS containing 3% FBS overnight, followed by a secondary antibody consisting of biotinylated anti-rabbit IgG (Vector Laboratories, Inc.) diluted to 1:200 in PBS containing 3% FBS. Streptavidin-fluorescein (1:200 dilution, Boeringer Mannheim) was used to visualize the stained cells by confocal microscopy (Nikon, Japan).
Flow Cytometric Analysis for HIF-1α Expression--Cells
4',6-Diamidino-2-phenylindole (DAPI) was used to stain nuclei.
Reporter Gene Assays--The HRE-Luc, containing four copies of the erythropoietin hypoxiaresponsive element, i.e., 5'-GATCGCCCTACGTGCTGTCTCA-3', Gal4-tk-Luc containing Gal4 binding site, and the VEGF promoter (-2068 to +50)-Luc reporter constructs have been described elsewhere (17, 29, 30) .
The eukaryotic expression vector for wild type HBx, HpSVX, the vector encoding frameshift mutant of HBx, pSVXkB, and the dominant negative mutants of p42 and p44, pERK1KR and pERK2KR, respectively, were as described previously (17, 31) . The eukaryotic expression vector encoding full-length HIF-1α, and pGal4-HIF-1α, containing the DNA binding domain (1-147 amino acids) of Yeast Gal4 linked to the full-length coding region of mouse HIF-1α as described previously (17 Biotech.) at 4°C overnight, followed by treatment with anti-mouse IgG antibodies (Vector Laboratories, Inc.).
Sections were incubated with an avidin-biotin complex conjugated to horseradish peroxidase. To better visualize the positive cells, color development was enhanced by diaminobenzidine and counter-stained by hematoxylin.
RESULTS
HBx increases stability of HIF-1α protein --Since the role of HBx is implicated in angiogenesis and metastasis during hepatocarcinogenesis, we examined whether HBx directly modulate the transcriptional activity of HIF-1α which is a critical inducer of tumor angiogenesis. Transcriptional activity of HIF-1α is primarily regulated by accumulation of HIF-1α protein under hypoxic stress, which otherwise rapidly degraded by ubiquitin-proteasome pathway in normoxic cell (11, 12) . Therefore, we tested whether HBx induced accumulation of HIF-1α. For this purpose, we employed the Chang X-34 cell line, in which the expression of HBx gene is under control of an inducible doxycycline promoter (4, 28, 31) . After Chang X- 
HBx increases nuclear translocation and phosphorylation of HIF-1α--For transcriptional activation
of HIF-1α, the protein is required to translocate into nucleus (35) . Therefore, we analyzed whether HBx influenced the subcellular localization of HIF-1α by immunofluorescence studies. As shown in cells by SDS-PAGE with an 8% gel ( Fig. 3 ). Interestingly enough, the HIF-1α band was clearly separated into a fast and a slow migrating band. The slow migrating band which represents phosphorylated and active status of HIF-1α appeared in Chang X-34 cells, and it became the most striking in the presence of both doxycycline and CoCl 2 . In the same cell lysates, the p42/p44 MAPK was strongly activated when evaluated by Western blotting analysis using anti-phospho p42/p44 antibodies. When we employed a different doxycycline-inducible Chang cell clone, Chang X-31, basically the same results were obtained. However, the degree of both HIF-1α and p42/p44 MAPK activation was lower without doxycycline treatment in Chang X-31, which could be due to the lower leaky expression of HBx in the clone (34) . These results may suggest that HIF-1α is phosphorylated by p42/p44 MAPK in the presence of HBx.
HBx expression vector together with a reporter gene containing HRE sequences that locates in the erythropoietin gene promoter (29) . As shown in Fig. 4 , co-transfection of HBx expression vector into HepG2 cells activated the HRE reporter gene activity in a dose-dependent manner, while the frameshift mutant HBx expression vector did not induce significant changes. To test whether the induction was directly due to transcriptional activation of HIF-1α, we employed a Gal4-driven reporter system (17) . We cotransfected a pGal4/HIF-1α plasmid that encodes full-length mouse HIF-1α linked to the DNA binding domain of yeast Gal4 together with the reporter plasmid containing Gal4 binding sequences and thymidine kinase (tk) promoter. Since the Gal4 fusion protein is able to bind Gal4 binding site, the reporter gene is transcribed only when HIF-1α has transcriptional activity (17) . Co-transfection of wild-type HBx enhanced
Gal4-tk-Luc activity in a dose-dependent manner. Similar results were obtained using a luciferase reporter containing a VEGF promoter fragment (-2068 to +50), which includes a HRE (30) . Together, these results
indicate that HBx induced transcriptional activity of HIF-1α through direct regulation of HIF-1α.
Interestingly, the expression of HBx in the presence of CoCl 2 remarkably activated all three reporter activities (Fig. 4) . The synergistic increases of the reporter activity by HBx and hypoxia may suggest a strong cooperation of hypoxia and HBx for maximal activation of HIF-1α.
HBx induces transcriptional activity of HIF-1α through activation of MAPK signaling pathway-
To further test the involvement of p42/p44 MAPK signaling pathway in HBx-induced transcriptional activity of HIF-1α, we examined whether the HBx-induced HIF-1α activity was repressed by blocking p42/p44
MAPK pathway. As shown in Fig. 5A , PD98059 efficiently blocked the Gal4-HIF-1α driven Gal4-tk-Luc activity that was induced by HBx. Further, the dominant negative mutants of p42/p44 MAPK, ERK1KR
and ERK2KR repressed the HBx-induced HIF-1α activity dose-dependently, suggesting that HBx induces transcriptional activity of HIF-1α through activation of MAPK signaling pathway (Fig. 5B) (Fig. 6C) . Consistent with the results, PD98059 largely decreased the HBx-induced stability of HIF-1α that measured in the presence of cycloheximide (Fig. 6D ). When we examined the localization of HIF-1α after PD98059 treatment, most of the protein was present in cytosol, although the intensity of fluorescence was significantly diminished (Fig. 6E ). Taken together, these results demonstrated that p42/p44 MAPK signaling pathway was strongly involved in the HBx-induced HIF-1α activation.
Next, we investigated the molecular mechanism by which HBx enhances stabilization HIF- 
The expression of HIF-1α as well as VEGF was increased in liver tissues of HBx-transgenic mice-
Finally, we examined the expression and function of HIF-1α in liver samples obtained from the HBx transgenic mice (32) . As expected, the expression of HIF-1α was increased along with the age of the HBx transgenic liver, whereas the expression of HIF-1α was barely detectable in liver samples obtained from the C57BL/6 wild-type control mice (Fig. 9A) . To further study the transcriptional function of HIF-1α in the HBx transgenic mice, we examined the expression of VEGF, a downstream target of HIF-1α. As expected, an age-dependent increase of VEGF expression was observed in the HBx-transgenic liver (Fig. 9A) . Upon microscopic examination of the liver tissue immunohistochemistry, we found that VEGF proteins diffusely localized in the cytosol of hepatocytes that were located proximal to the central vein in the liver tissues of 7-month old HBx transgenic mice. This observation was increasingly distinct along with the age of the HBx transgenic mice, in that VEGF staining was widely spread in the liver of 13-month old transgenic mice, while the protein was not detected in the liver tissues that were obtained from the age-matched B6 wild-type control mice. Such MEK-1/p42/p44 MAPK activity was necessary for the full activation of HIF-1α as a transactivator under hypoxia and PD98059 did not block the stabilization or DNA binding ability of HIF-1α (17) . We also demonstrated that HBx activates MEK-1/p42/p44 MAPK pathway that induces transcriptional activation as well as nuclear translocation of HIF-1α (Figs. 5 and 6 ). However, the stability of HIF-1α protein in the presence of HBx was very sensitive to decrease by PD98059 treatment (Fig. 6) , indicating that the HBxinduced MAPK signaling network plays an important role in the stabilization of HIF-1α, which was contrast to the previous reports. Meanwhile the protein level of HIF-1α that induced by both HBx and CoCl 2 was not decreased so sensitively (Fig. 6B) . Therefore, our results suggest that the HBx-induced MAPK signaling network plays an important role in the stabilization of HIF-1α, which may be distinct from that induced by hypoxia. HBx may activate a different set of MAPK signaling molecules that may include yet unknown target molecules which are critical for HIF-1α stabilization.
Generally, a local hypoxia is generated during hepatocarcinogenesis due to the shortage of blood supply caused by portal hypertension in cirrhotic lesions and rapid proliferation of tumor cells in liver tissues and HBx could not only provide the important implications for angiogenesis and tumor progression but also a valuable strategy to treat HBV-associated hepatocarcinogenesis.
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